Dimethyl fumarate in cutaneous T-cell lymphoma, lipid nanoparticles for editing of human hematopoietic cells, and racial and geographic disparities in lymphoma trials
This episode covers dimethyl fumarate treatment for cutaneous T-cell lymphoma, the application of lipid nanoparticles in editing human hematopoietic cells, and examines racial and geographic disparities within lymphoma clinical trials.